IndraLab
Statements
Methylene blue inhibits NLRP3. 21 / 21
|
1
20
reach
"HIGHLIGHTS - Cytogenetic abnormalities and innate immune activation are seen in myelodysplasia - The NLRP3 inflammasome is a core element generating marrow failure of myelodysplasia - In April 2018 methylene blue was reported to potently inhibit NLRP3 inflammasome function - Methylene blue has benign side effects and has been in human use for a century - Study of methylene blue treatment of myelodysplasia would be a low-risk intervention Introduction -- myelodysplasia."